Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe crawled date : 2021 - 09 - 16 save search
F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021Preclinical Data Indicates a Broad Therapeutic Window for F-star’s First-in-Class Tetravalent Dual T cell Agonist
Published: 2021-09-16 (Crawled : 13:15) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -0.28%
H: 0.71%
C: -0.43%
phase 1 trial t-cell
Gerdau Graphene Presents Its Chief Technology Officer (Europe And Asia), Based On Its R&D Center At The University of Manchester
Published: 2021-09-16 (Crawled : 13:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.8%
H: 1.57%
C: 1.13%
europe technology
Updated regulatory timeline for review of MAA in Europe
Published: 2021-09-16 (Crawled : 13:00) - prnewswire.com
CALT | $18.385 -1.68% -1.71% 2.9K
|
Health Technology
|
| O: -2.29%
H: 1.26%
C: 0.23%
europe
BeyondSpring Pharmaceuticals Announces New Positive Data on Plinabulin from Its Chemotherapy-Induced Neutropenia Prevention Program at the European Society for Medical Oncology 2021 Congress
Published: 2021-09-16 (Crawled : 11:00) - beyondspringpharma.com
BYSI | $2.11 10.47% 9.48% 64K
|
Health Technology
|
| O: 0.35%
H: 0.95%
C: -2.34%
europe positive therapy plinabulin
Zanidatamab Phase 2 Clinical Trial Demonstrates Promising Response Rate and Durability in First-Line HER2-Positive Gastroesophageal Adenocarcinoma (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress
Published: 2021-09-16 (Crawled : 11:00) - biospace.com/
ZYME | $8.72 -1.47% -1.49% 420K
|
Health Technology
|
| O: 10.51%
H: 1.37%
C: -1.1%
BGNE | $131.15 1.26% 1.24% 150K
|
Health Technology
|
| O: 1.72%
H: 1.18%
C: 0.9%
phase 2 europe positive trial her2+ her2- her2
Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand
Published: 2021-09-16 (Crawled : 09:00) - biospace.com/
TVTX | $5.85 2.27% 2.22% 1.1M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -4.2%
commercialization europe license pharma
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.